Suchergebnisse - "O'Connor, Owen A"

PubPharm (287)

81

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

enthalten in: Leukemia & lymphoma | 2016

von Bartlett, N. | Smith, M. | Siddiqi, T. | +13

82

Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma

enthalten in: British journal of haematology | 2016

von Kalac, M. | Lue, J. | Lichtenstein, E. | +9

83

Emerging therapies in relapsed and refractory peripheral T-cell lymphoma

enthalten in: Clinical advances in hematology & oncology : H&O | 2015

von Bachow, S. | O'Connor, O.

84

Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD) : a 120 case single institution series

enthalten in: British journal of haematology | 2015

von Montanari, F. | Radeski, D. | Seshan, V. | +3

CommentIn: Br J Haematol. 2017 Dec;179(5):854-856. - PMID 27448018

85

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Amengual, J. | Johannet, P. | Lombardo, M. | +12

86

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma

enthalten in: British journal of haematology | 2015

von Marchi, E. | Zullo, K. | Amengual, J. | +11

87

Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Zullo, K. | Guo, Y. | Cooke, L. | +10

88

Epigenetics and Lymphoma : Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

enthalten in: Current oncology reports | 2015

von Lue, J. | Amengual, J. | O'Connor, O.

89

Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma : a perspective review

enthalten in: Therapeutic advances in hematology | 2015

von Sawas, A. | Radeski, D. | O'Connor, O.

90

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma : Results of the Pivotal Phase II BELIEF (CLN-19) Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von O'Connor, O. | Horwitz, S. | Masszi, T. | +14